Dogs With Congestive Heart Failure Have Significantly Improved Survival Outcomes With Vetmedin(R) (pimobendan)

Veterinarians and dog owners are welcoming new research that delivers the promise of an extended happy life together for millions of dog owners and their pets. The three-year study demonstrates that dogs suffering from the most common type of heart failure live on average 91% (267 days vs. 140 days) longer when treated with the product Vetmedin(R) (pimobendan) compared with another common treatment option(1).

More: continued here

Filed under: Veterinary on September 8th, 2008